The Socio-Economic Impact of Interoperable EHR and ePrescribing Systems in Europe and Beyond

Article of the Month!

The Socio-Economic Impact of Interoperable Electronic Health Record (EHR) and ePrescribing Systems in Europe and Beyond - Final Report
The European Commission EHR IMPACT study (EHRI) investigates the socio-economic impact of interoperable Electronic Health Record (EHR) and ePrescribing systems in Europe and beyond. Core to the project is a detailed qualitative analysis of eleven good practice cases in Europe, USA and Israel. Nine of these underwent also a quantitative evaluation of their socioeconomic impacts. Each application studied is a sustainable solution in routine operation.

This final report of the EHR IMPACT study addresses the conceptual framework for understanding and interpreting the study results, the study design and approach, and the essence of the impact analysis results.

The study takes a broad perspective of EHRs and ePrescribing. An EHR system can include parts of a comprehensive record, allows limited or extensive sharing of information, or may be part of a particular healthcare provider organisation (HPO) patient record. It usually does not contain all the health-related life-long data about people, often envisaged by grand strategies. ePrescribing is usually part of a wider health information system and often includes information on prescribing policies, clinical decision and dispensing support, advice to patients and carers, and tools to facilitate the processes and roles of each stakeholder needed to convert prescribing decisions into administered medications.

Interoperability is defined as the ability to exchange, understand and act on patient and other health information and knowledge among linguistically and culturally disparate clinicians, patients and other actors, within and across jurisdictions, in a collaborative manner. EHRI distinguishes between three levels of interoperability, which are potential interoperability, limited connectivity, and extended actual connectivity.

The goals of the EHR IMPACT study required an inductive, empirical approach. Two perspectives were applied, the socio-economic, and a narrower, financial one within the socio-economic. This dual perspective in the EHR IMPACT methodology provides a rigorous evaluation of the long-term impacts of interoperable EHR and ePrescribing systems. The case studies provide empirical insights that underpin findings on the socio-economic impact of interoperable EHR and ePrescribing systems and the factors that need to be in place to accelerate their successful deployment.

Download The Socio-Economic Impact of Interoperable Electronic Health Record (EHR) and ePrescribing Systems in Europe and Beyond - Final Report (.pdf, 581 KB).

Download from the eHealthNews.EU Portal's mirror: The Socio-Economic Impact of Interoperable Electronic Health Record (EHR) and ePrescribing Systems in Europe and Beyond - Final Report (.pdf, 581 KB).

For further information, please visit:
http://www.ehr-impact.eu

Related news articles:

About empirica
empirica Gesellschaft für Kommunikations- und Technologieforschung mbH (empirica) has many years of experience in quantitative and qualitative research methods. Its clients are private companies and public bodies: large and medium-sized companies in the insurance, pharmaceutical and automobile industries as well as software developers and hardware manufacturers. There are also telecommunications service companies and network providers, social services firms, medical facilities, Federal and State Government ministries in Germany and the European Commission as well as the European statistical office (Eurostat). For further information, please visit www.empirica.com.

Most Popular Now

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Elsevier Adds to its Extensive Free Reso…

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and...

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

An EU Approach for Efficient Contact Tra…

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. This...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...